Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well pemetrexed disodium and carboplatin work in treating
patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. Drugs used in
chemotherapy, such as pemetrexed disodium and carboplatin, work in different ways to stop the
growth of tumor cells, either by killing the cells or by stopping them from dividing.
Phase:
Phase 2
Details
Lead Sponsor:
Albert Einstein College of Medicine Albert Einstein College of Medicine of Yeshiva University